The case stems from a friendship-based investment scheme where defendants Samuel and Nadine Wohlstadter allegedly enticed longtime friends Michael A. Manzo, Michael K. Manzo, Louis Manzo, and Dr. Paul Auwaerter to invest substantial funds in Wellstat, a biopharmaceutical company. Defendants allegedly failed to disclose that Wellstat was in dire financial straits, subject to an $82.6 million debt obligation, and barred from incurring further debt, while falsely claiming the investment would fund a new spinoff company called Wellmond that was never actually formed.
Circuit Judge William J. Kayatta Jr. rejected plaintiffs' narrow interpretation of "arising out of," finding that even under plaintiffs' preferred definition, the lawsuit clearly originated from the promissory notes. "Resolving the suit requires interpreting the notes," Kayatta wrote, noting that the complaint describes itself as arising under securities laws and "trains repeatedly on statements in the notes as the affirmative misrepresentations giving rise to this lawsuit." The court emphasized that plaintiffs failed to identify any injury that would have existed without purchasing the notes.
The district court had dismissed the Massachusetts federal lawsuit without prejudice after defendants moved to enforce forum selection clauses in the promissory notes requiring litigation in Delaware courts. Plaintiffs argued the clause didn't apply because their fraud claims preceded the notes' execution and because defendants were being sued personally rather than in their corporate capacity.
The First Circuit also rejected plaintiffs' public policy challenge, finding they failed to meet the "heavy burden" required to void forum selection clauses. The court noted that Massachusetts securities law claims are "not uncommonly brought in other jurisdictions" and that plaintiffs offered no evidence Delaware courts would refuse to hear their state-law claims, with the only identified harm being the time and expense of out-of-state litigation.